Sumilor

Sumilor (tacrolimus) is a topical calcineurin inhibitor for cutaneous use, prescribed to manage moderate to severe eczema. It reduces inflammation and itching in affected skin areas. This non-steroidal treatment is suitable for adults and children aged 2+. Always follow healthcare guidance when using.

Sumilor (tacrolimus) is used to treat moderate to severe atopic dermatitis, also known as eczema. It helps reduce redness, itching, and inflammation in sensitive skin areas where topical steroids may not be suitable. The ointment works by modulating the immune response in the skin, providing relief for flare-ups. It is often recommended when other treatments have not been effective.

Sumilor (tacrolimus) ointment works by calming overactive immune responses in the skin, which can reduce redness, swelling, and itching associated with eczema. Users may notice improved skin texture and fewer flare-ups with consistent application. Some people experience a temporary warming or tingling sensation when first applying the product.

Sumilor (tacrolimus) is for external use only and should not be applied to open wounds or infected skin. Avoid contact with eyes, mouth, or mucous membranes. Wash hands before and after application unless treating hand eczema. Keep the product away from heat and direct sunlight. Do not use on children under 2 without medical advice.

Sumilor (tacrolimus) has minimal systemic absorption, but it may interact with other topical medications applied to the same area. Avoid using it alongside strong corticosteroids unless directed by a healthcare provider. Inform your doctor if you are using other immune-suppressing drugs. Alcohol-based products or harsh cleansers may increase skin sensitivity when used with tacrolimus.